Suchergebnisse
Suchergebnisse:
QIAGEN delivers Sample to Insights solutions that enable customers to unlock insights from the building blocks of life - DNA, RNA and proteins.
Qiagen N.V. ist ein börsennotierter Anbieter von Probenvorbereitungs- und Testtechnologien für die molekulare Diagnostik, akademische Forschung, pharmazeutische Industrie und angewandte Testverfahren mit Standorten in mehr als 25 Ländern.
QIAGEN AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie QIAGEN N.V. | A400D5 | QGEN | NL0015001WM6.
QIAGEN offers advanced molecular testing solutions that move customers through the whole process – faster, better and more efficiently. We identify bottlenecks, solve problems and exceed expectations. It’s who we are. Find out more about QIAGEN’s vision, identity and mission.
Wenn Sie Fragen zu QIAGEN, unseren Produkten oder Ihrer Bestellung haben, finden Sie auf dieser Seite die Antworten und Kontakte, die Sie benötigen. Wir haben Büros auf der ganzen Welt, um unsere internationalen Kunden zu unterstüt-zen.
Thank you for choosing QIAGEN. If you have questions about QIAGEN, our products or your order, this page should help you find the answers and contacts you need. QIAGEN Subsidiaries; Commercial Partner and Distributor Solutions; QIAGEN Divisions
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries.
50% off QIAseq ® FastSelect ™. Optimize your RNA-seq workflow with QIAseq FastSelect and remove >95% rRNA in one step.
7. Feb. 2024 · Qiagen hat ein solides viertes Quartal abgeliefert und will, wie vom Markt auch antizipiert, zum Wachstum bei Umsatz und Gewinn zurückkehren. Die weiteren Monate könnten bei der Aktie allerdings...
17. Juni 2024 · Der Diagnostikspezialist und Laborzulieferer Qiagen hat im heutigen Handel ein beeindruckendes Intraday-Reversal aufs Parkett gezaubert. Ausschlaggebend sind die Information, die das Unternehmen...
Unlock high-quality biomedical data and relationships for knowledge graphs, AI-driven target identification and more. QIAGEN Biomedical Knowledge Bases provide critical biomedical relationships information, structured and integrated manually and by AI.
Der aktuelle Qiagen Realtimekurs (19:17:50) liegt bei 39,24 €. Damit ist die Qiagen Aktie (A400D5) in 24 Stunden um +0,04 % gestiegen. Auf 7 Tage gesehen hat sich der Kurs der Qiagen Aktie...
B.S Science. Associate Director, Global Development Lead Immune Response at QIAGEN · Experience: QIAGEN · Location: Arlington · 212 connections on LinkedIn. View Frank Stieber’s profile on ...
- QIAGEN
About QIAGEN. Our products. Understanding DNA, RNA and proteins – the molecular building blocks of life – is changing the way our world diagnoses and treats diseases, protects public safety, and advances science.
Skilled in Bioinformatics, Genetics, Statistics, and Research. Strong experience in R… · Experience: QIAGEN · Education: Grand Valley State University · Location: Warren · 500+ connections ...
- QIAGEN
Hier finden Sie Tipps und Tools für reproduzierbare und standardisierte PCR-Ergebnisse unter Verwendung zuverlässiger, hochwertiger PCR-Produkte.
View Anna Fulbright’s profile on LinkedIn, the world’s largest professional community. Anna has 1 job listed on their profile.
- QIAGEN
Our global QIAGEN team is known to more than 500,000 customers around the world across the continuum from research in the life sciences to molecular diagnostics and public safety applications in everyday use. But Sample to Insight is more than just about providing smooth, end-to-end workflows.
Solutions for Laboratory-Developed Tests. Assays for pathogen detection and viral load monitoring. Complete validated workflows provide standardized and reliable solutions for routine testing. Expand your latent TB testing with our range of manual and automated immune response technologies.
For detection of multiple hallmark mutations in cancer-relevant genes using the QIAcuity digital PCR instruments. Our digital PCR assays, kits and instruments deliver high accuracy and sensitivity, with advanced multiplexing and scalable throughputs.
A strong commitment to cybersecurity is crucial, especially in turbulent times like these. And the best way to approach it is not necessarily as spending on outsourced services, but as investing in the right in-house capabilities. Daniel Schatz, Chief Information Security Officer of QIAGEN.
